Literature DB >> 22833182

Myocardial infarction changes sphingolipid metabolism in the uninfarcted ventricular wall of the rat.

Małgorzata Knapp1, Małgorzata Zendzian-Piotrowska, Krzysztof Kurek, Agnieszka Błachnio-Zabielska.   

Abstract

It is known that the ratio, the level of sphingosine-1-phosphate (S1P)/the level of ceramide (CER) determines survival of the cells. The aim of the present study was to examine the effect of myocardial infarction on the level of different sphingolipids in the uninfarcted area. The experiments were carried out on male Wistar rats: 1, control; 2, after ligation of the left coronary artery (infarct) and 3, sham operated. Samples of the uninfarcted area of the left ventricle were taken in 1, 6 and 24 h after the surgery. The level of sphingolipids, S1P, CER, sphingosine (SPH), sphinganine-1-phosphate (SPA1P) and sphinganine (SPA) was determined. The control values were (ng/mg), S1P-0.33 ± 0.03, SPH-1.02 ± 0.13, SPA1P-0.11 ± 0.01, SPA-0.28 ± 0.04, total CER-20.3 ± 1.8. In infarct, the level of S1P in the uninfarcted area was reduced by ~3 times in 1 and 6 h and decreased further in 24 h. The level of SPH decreased in 1 h and returned to the control thereafter. The total level of CER decreased in 6 h after the infarction. Sham surgery also produced changes in the level of certain sphingolipids. The ratio, the level of S1P/the level of CER was markedly reduced at each time point after the infarction. It is concluded that the reduction in the S1P/CER ratio could be responsible for increased apoptosis in the uninfarcted area after the myocardial infarction in the rat.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22833182     DOI: 10.1007/s11745-012-3694-x

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  29 in total

Review 1.  Physiology and pathophysiology of sphingolipid metabolism and signaling.

Authors:  A Huwiler; T Kolter; J Pfeilschifter; K Sandhoff
Journal:  Biochim Biophys Acta       Date:  2000-05-31

Review 2.  Sphingosine 1-phosphate, a key cell signaling molecule.

Authors:  Sarah Spiegel; Sheldon Milstien
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

Review 3.  Cardioprotective role of sphingosine-1-phosphate.

Authors:  Malgorzata Knapp
Journal:  J Physiol Pharmacol       Date:  2011-12       Impact factor: 3.011

Review 4.  The role of sphingolipids in the process of signal transduction.

Authors:  L Riboni; P Viani; R Bassi; A Prinetti; G Tettamanti
Journal:  Prog Lipid Res       Date:  1997-09       Impact factor: 16.195

Review 5.  An overview of sphingolipid metabolism: from synthesis to breakdown.

Authors:  Christopher R Gault; Lina M Obeid; Yusuf A Hannun
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

6.  Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats.

Authors:  D X Zhang; R M Fryer; A K Hsu; A P Zou; G J Gross; W B Campbell; P L Li
Journal:  Basic Res Cardiol       Date:  2001 May-Jun       Impact factor: 17.165

7.  Effect of acute exercise on the content of free sphinganine and sphingosine in different skeletal muscle types of the rat.

Authors:  A Dobrzyń; J Górski
Journal:  Horm Metab Res       Date:  2002-09       Impact factor: 2.936

8.  A liquid chromatography/tandem mass spectrometry method for measuring the in vivo incorporation of plasma free fatty acids into intramyocellular ceramides in humans.

Authors:  Agnieszka U Blachnio-Zabielska; Xuan-Mai T Persson; Christina Koutsari; Piotr Zabielski; Michael D Jensen
Journal:  Rapid Commun Mass Spectrom       Date:  2012-05-15       Impact factor: 2.419

Review 9.  Sphingolipid therapy in myocardial ischemia-reperfusion injury.

Authors:  Susheel Gundewar; David J Lefer
Journal:  Biochim Biophys Acta       Date:  2007-09-06

Review 10.  Sphingosine kinase and sphingosine 1-phosphate in cardioprotection.

Authors:  Joel S Karliner
Journal:  J Cardiovasc Pharmacol       Date:  2009-03       Impact factor: 3.105

View more
  9 in total

Review 1.  Implication of sphingosin-1-phosphate in cardiovascular regulation.

Authors:  Ningjun Li; Fan Zhang
Journal:  Front Biosci (Landmark Ed)       Date:  2016-06-01

2.  Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets.

Authors:  Masahito Kawabori; Rachid Kacimi; Joel S Karliner; Midori A Yenari
Journal:  World J Cardiol       Date:  2013-04-26

Review 3.  Sphingolipids in cardiovascular diseases and metabolic disorders.

Authors:  Sonia Borodzicz; Katarzyna Czarzasta; Marek Kuch; Agnieszka Cudnoch-Jedrzejewska
Journal:  Lipids Health Dis       Date:  2015-06-16       Impact factor: 3.876

4.  Sphingolipids metabolism in the salivary glands of rats with obesity and streptozotocin induced diabetes.

Authors:  Marta Garbowska; Bartłomiej Łukaszuk; Agnieszka Mikłosz; Igor Wróblewski; Krzysztof Kurek; Lucyna Ostrowska; Adrian Chabowski; Małgorzata Żendzian-Piotrowska; Anna Zalewska
Journal:  J Cell Physiol       Date:  2017-04-27       Impact factor: 6.384

5.  Identification of Novel miRNAs Involved in Cardiac Repair Following Infarction in Fetal and Adolescent Sheep Hearts.

Authors:  Mitchell C Lock; Ross L Tellam; Jack R T Darby; Jia Yin Soo; Doug A Brooks; Mike Seed; Joseph B Selvanayagam; Janna L Morrison
Journal:  Front Physiol       Date:  2020-06-10       Impact factor: 4.566

Review 6.  Unique Roles of Sphingolipids in Selected Malignant and Nonmalignant Lesions of Female Reproductive System.

Authors:  Paweł Knapp; Karolina Chomicz; Magdalena Świderska; Adrian Chabowski; Robert Jach
Journal:  Biomed Res Int       Date:  2019-05-02       Impact factor: 3.411

7.  Screening of sphingolipid metabolism-related genes associated with immune cells in myocardial infarction: a bioinformatics analysis.

Authors:  Jijuan Wang; Ping Wang; Weihua Wang; Huiling Jin
Journal:  J Thorac Dis       Date:  2022-08       Impact factor: 3.005

8.  Plasma Metabolic Profile Determination in Young ST-segment Elevation Myocardial Infarction Patients with Ischemia and Reperfusion: Ultra-performance Liquid Chromatography and Mass Spectrometry for Pathway Analysis.

Authors:  Lei Huang; Tong Li; Ying-Wu Liu; Lei Zhang; Zhi-Huan Dong; Shu-Ye Liu; Ying-Tang Gao
Journal:  Chin Med J (Engl)       Date:  2016-05-05       Impact factor: 2.628

9.  Implication of Sphingolipid Metabolism Gene Dysregulation and Cardiac Sphingosine-1-Phosphate Accumulation in Heart Failure.

Authors:  Lorena Pérez-Carrillo; Isaac Giménez-Escamilla; Luis Martínez-Dolz; Ignacio José Sánchez-Lázaro; Manuel Portolés; Esther Roselló-Lletí; Estefanía Tarazón
Journal:  Biomedicines       Date:  2022-01-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.